# Gastric Cancer Organoids in the Screening of Neoadjuvant Drugs

> **NCT06196554** · — · UNKNOWN · sponsor: **Dong Bing Zhao** · enrollment: 40 (estimated)

## Conditions studied

- Gastric Cancer
- Organoid
- Neoadjuvant Therapy

## Interventions

- **DRUG:** Oxaliplatin

## Key facts

- **NCT ID:** NCT06196554
- **Lead sponsor:** Dong Bing Zhao
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-05-01
- **Primary completion:** 2024-06-28
- **Final completion:** 2024-06-28
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2024-01-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06196554

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06196554, "Gastric Cancer Organoids in the Screening of Neoadjuvant Drugs". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06196554. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*